Researchers in Sweden say a tool, known as Stockholm3, finds 90 per cent of 'clinically significant' prostate cancers, compared with 74 per cent uncovered by the standard prostate-specific antigen ...
In the new guidance, the agency has concluded that AI-Rad Companion Prostate MR, DeepHealth Prostate, ProstatID, Prostate ...
WASHINGTON — A new study by the Medical University of Vienna found that a specialized form of imaging could identify 91% of prostate cancer cases without the need for a biopsy. Traditionally, a blood ...